Compare Abeona Therapeutics Inc (ABEO) vs Vital Farms Inc (VITL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Vital Farms Inc — how do they compare? Abeona Therapeutics Inc trades at $6.76 (market cap $373.32M), while Vital Farms Inc trades at $12.39 (market cap $563.24M). The key difference: Vital Farms Inc is the larger of the two by market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Vital Farms Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | VITL | |
|---|---|---|
Market Cap | $373.32M | $563.24M |
Sector | Health | Consumer Staples |
52-Week High | $7.23 | $52.41 |
52-Week Low | $4.17 | $8.28 |
Enterprise Value | $228.22M | $566.05M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Vital Farms (VITL) trades at $12.84, up 0.63% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported 2025 revenue of $759.44M and net income of $66.28M, though earnings have missed expectations in recent quarters. Analysts maintain a Buy consensus with a $14.00 price target, but negative cash flow and a class action lawsuit pose headwinds.
The stock offers value with a P/E of 12.35 and P/S of 0.75, but risks include declining profitability, legal challenges, and sustained negative cash flow. Upside depends on execution improvements and resolving litigation, while failure to stabilize earnings could pressure valuations further.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
